Gohealth, Inc. · NASDAQ:GOCO
Gohealth — Q2 2024 Earnings Presentation
10 slides from Gohealth's earnings presentation, Aug 8, 2024
Slide 1: Second Quarter 2024 Results
Second Quarter 2024 Results August 8, 2024 1
Slide 2: Forward-Looking Statements
Forward-Looking Statements This earnings presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking
Slide 3: Use of Non-GAAP Financial Measures and Key Performance Indicators
Use of Non-GAAP Financial Measures and Key Performance Indicators Non-GAAP Financial Measures In this earnings presentation we use supplemental measures of our performance that are derived from our consolidated financial information, but which are not presented in our Condensed Consolidated Financia
Slide 4: Reported Financial Comparison Year-over-Year
Reported Financial Comparison Year-over-Year Revenue and Adjusted EBITDA comparisons for the second fiscal quarter Q2’23 TO Q2’24 Q2’23 TO Q2’24 REVENUE COMPARISON ($M)1 ADJ. EBITDA COMPARISON ($M)1,2 Q2'23 Q2'24 1. Numbers may not sum due to rounding. There may be slight differences compared to num
Slide 5: Cash Flow from Operations Year-to-Date and Trailing Twelve Months
Cash Flow from Operations Year-to-Date (“YTD”) and Trailing Twelve Months (“TTM”) TTM Cash Flow is a liquidity measure that normalizes quarterly seasonality YTD CASH FLOW FROM TTM CASH FLOW FROM OPERATIONS ($M)1 OPERATIONS ($M)1 1. Numbers may not sum due to rounding. There may be slight differences
Slide 6: Medicare Unit Economics Year-over-Year
Medicare Unit Economics Year-over-Year Decrease in Adjusted Direct Operating Margin per Submission driven by lower Sales per Submission, partially offset by lower Direct Cost per Submission ADJUSTED DIRECT OPERATING MARGIN SALES PER SUBMISSION1 3 PER SUBMISSION UNIT ECONOMICS $852 $690 PER SUBMISSIO
Slide 7: Appendix
Appendix 7
Slide 8: Appendix - Reconciliation of Net Income to Adjusted EBITDA
Appendix - Reconciliation of Net Income to Adjusted EBITDA ($ in thousands) 8
Slide 9: Appendix – TTM Financial Comparison Year-over-Year
Appendix – TTM Financial Comparison Year-over-Year TTM Revenue and Adjusted EBITDA growth YoY Q2’23 TTM to Q2’24 TTM REPORTED Q2’23 TTM to Q2’24 TTM REPORTED REVENUE COMPARISON ($M)1 ADJ. EBITDA COMPARISON ($M)1,2 1. Numbers may not sum due to rounding. There may be slight differences compared to nu
Slide 10: Appendix - Reconciliation of Medicare Revenue per Submission and Operating Expense per Submission
Appendix - Reconciliation of Medicare Revenue per Submission and Operating Expense per Submission to Sales per Submission and Direct Cost per Submission ($ in thousands) 10